Results 161 to 170 of about 1,090,016 (327)

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

open access: yesThe Lancet Oncology, 2019
J. Primrose   +27 more
semanticscholar   +1 more source

Genetic Aberrations in Normal Tissues Adjacent to Biliary Tract Cancers. [PDF]

open access: yesBiomedicines
Kwon CH   +8 more
europepmc   +1 more source

Integrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma

open access: yesJournal of Hepatocellular Carcinoma
Juan Zhang,1,* Yingyu Xu,2,* Xiaojian Ni,2,* Zhiyi Mao,3,* Haitao Xiao,4 Maopei Chen,1 Youpei Lin,5 Jiaomeng Pan,5 Boheng Zhang,6 Lan Zhang,1 Xueying Zheng,3 Guohe Song,5 Ningling Ge1 1Department of Hepatobiliary Oncology,
Zhang J   +12 more
doaj  

Genetic associations of cholelithiasis and biliary tract cancer. [PDF]

open access: yesTransl Oncol
Jiang Y   +13 more
europepmc   +1 more source

Supplementary Figure S1 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

open access: gold, 2023
Arathi Mohan   +17 more
openalex   +1 more source

Abdominal lymph node tuberculosis mimicking malignant obstructive jaundice in a young woman

open access: yesAsian Journal of Surgery, 2023
Xiwen Ye, Yulong Cai, Zhen You
doaj   +1 more source

Role of Radiation Therapy for Biliary Tract Cancers. [PDF]

open access: yesCurr Oncol
Chakraborty MA   +6 more
europepmc   +1 more source

First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study [PDF]

open access: gold
Guo‐Ming Shi   +22 more
openalex   +1 more source

Home - About - Disclaimer - Privacy